(UPDATED) There is no difference in in-hospital outcomes or longer-term mortality between patients undergoing revascularization with either a durable-polymer DES or newer technology with a ...
Washington, DC - Predicting the future is a fool's game, and predicting successful drug and device therapy in cardiovascular medicine is just as tricky. When bioabsorbable stents emerged on the radar ...
For about a decade, bioabsorbable stents were hailed as one of the most promising technologies in cardiology. Now, the future prospects of the technology are less than certain after a clinical trial ...
NEW ORLEANS, March 24 (Reuters) - An experimental drug-coated stent from Abbott Laboratories Inc. designed to be fully absorbed by the body appeared to be safe and effective in a tiny early-stage ...
CALGARY, Alberta--(BUSINESS WIRE)--Fluid Biomed Inc., a clinical stage medical device company developing lifesaving products for patients suffering from vascular disease, closed an oversubscribed $27 ...
When NICE looked at the evidence, it decided that there is not much good evidence about how well this procedure works or about its effect on quality of life. The 7 studies that NICE looked at involved ...
New York, July 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bioabsorbable Stents Market Research Report by Material, by Absorption Rate, by Application, by End ...
Landmark regulatory milestone makes the River stent available for adults with severe IIH – a debilitating, historically undertreated condition – who have failed medical therapy Serenity Medical ...
Rhinosinusitis is when the air‑filled cavities of the face (the sinuses) become infected and inflamed. It can cause facial pain and tenderness, a blocked or runny nose, fever and headache. Acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results